UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Annals of oncology, 2018-10, Vol.29 (10), p.2052-2060

2018

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab-related skin toxicity and efficacy: do we understand the mechanisms?

Annals of oncology, 2020-07, Vol.31 (7), p.964-965

2020

Link zum Volltext

Verfügbarkeit prüfen

Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study

Supportive care in cancer, 2020-04, Vol.28 (4), p.1639-1647

2020

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI)

Annals of oncology, 2019-07, Vol.30, p.iv21-iv21

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

ESMO open, 2022-08, Vol.7 (4), p.100529-100529, Article 100529

2022

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-01, Vol.33 (1), p.e15-e21

2021

Link zum Volltext

Verfügbarkeit prüfen

Nécrose digitale sous pembrolizumab : un évènement thrombotique rare

La revue de medecine interne, 2018-06, Vol.39, p.A198-A199

2018

Link zum Volltext

Verfügbarkeit prüfen

EP-1267: Induction chemotherapy followed by chemoradiotherapy in locally advanced pancreatic adenocarcinoma

Radiotherapy and oncology, 2016-04, Vol.119, p.S597-S597

2016

Link zum Volltext

Verfügbarkeit prüfen

Placement of metallic biliary endoprostheses in complex hilar tumours

Diagnostic and interventional imaging, 2012-10, Vol.93 (10), p.767-774

2012

Link zum Volltext

Verfügbarkeit prüfen

102P Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study

Annals of oncology, 2023-10, Vol.34, p.S220-S220

2023

Link zum Volltext

Verfügbarkeit prüfen

Mise en place d’endoprothèses biliaires métalliques dans les tumeurs hilaires complexes

Journal de radiologie diagnostique et interventionnelle, 2012-10, Vol.93 (10), p.814-821

2012

Link zum Volltext

Verfügbarkeit prüfen

SO-8 Predictive values of blood-based RNA signature for the FOLFIRINOX/FOLFOX response in advanced pancreatic cancer

Annals of oncology, 2023-06, Vol.34, p.S164-S165

2023

Link zum Volltext

Verfügbarkeit prüfen

Geriatric Assessment in older patients with pancreatic adenocarcinoma

Journal of geriatric oncology, 2023-11, Vol.14 (8), p.S37

2023

Link zum Volltext

Verfügbarkeit prüfen

1204MO PRODIGE 59 - DURIGAST trial: A randomised phase II study evaluating FOLFIRI plus durvalumab and FOLFIRI plus durvalumab plus tremelimumab in second-line treatment of patients with advanced gastric or gastro-oesophageal junction adenocarcinoma

Annals of oncology, 2022-09, Vol.33, p.S1099-S1100

2022

Link zum Volltext

Verfügbarkeit prüfen

LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial

Annals of oncology, 2022-09, Vol.33, p.S1390-S1391

2022

Link zum Volltext

Verfügbarkeit prüfen

Use of bevacizumab in elderly patients with metastatic colorectal cancer: Review

Journal of geriatric oncology, 2011-01, Vol.2 (1), p.64-71

2011

Link zum Volltext

Verfügbarkeit prüfen

1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)

Annals of oncology, 2023-10, Vol.34, p.S894-S895

2023

Link zum Volltext

Verfügbarkeit prüfen

1555P Cell-free DNA analysis in patients with metastatic gastroesophageal adenocarcinoma: Preliminary results of the REGIRI - PRODIGE 58 ancillary study

Annals of oncology, 2023-10, Vol.34, p.S871-S872

2023

Link zum Volltext

Verfügbarkeit prüfen

PO-1084: Stereotactic pelvic reirradiation for locoregional cancer relapse

Radiotherapy and oncology, 2020-11, Vol.152, p.S574-S574

2020

Link zum Volltext

Verfügbarkeit prüfen

IgG4-related systemic disease: Report of a case in an elderly patient

European geriatric medicine, 2012-10, Vol.3 (5), p.317-319

2012

Link zum Volltext

Verfügbarkeit prüfen

Transnational Trade Unionism: Building Union Power

First edition., 2013

Link zum Volltext

Verfügbarkeit prüfen

1566TiP PRODIGE 65 - UCGI 36 - GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma

Annals of oncology, 2020-09, Vol.31, p.S954-S955

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

Annals of oncology, 2019-10, Vol.30, p.v877-v878

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(124)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Comptes Rendus
(19)
Science & Technology
(18)
Physical Sciences
(11)
Physics
(10)
1800-1899
(8)
Barrès, Maurice
(7)
Exact Sciences And Technology
(7)
French Literature
(7)
Life Sciences & Biomedicine
(7)
Technology
(7)
Bolometers
(6)
Engineering
(6)
France
(6)
Histoire De La Littérature
(6)
Histoire Et Sciences De La Litterature
(6)
Littératures Francophones
(6)
Littératures Francophones Et Anglophones
(6)
Oncology
(6)
Revues Et Divers
(6)
Astronomy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Cetuximab-related skin toxicity and efficacy: do we understand the mechanisms?

Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study

Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI)

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse

Nécrose digitale sous pembrolizumab : un évènement thrombotique rare

EP-1267: Induction chemotherapy followed by chemoradiotherapy in locally advanced pancreatic adenocarcinoma

Placement of metallic biliary endoprostheses in complex hilar tumours

102P Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study

Mise en place d’endoprothèses biliaires métalliques dans les tumeurs hilaires complexes

SO-8 Predictive values of blood-based RNA signature for the FOLFIRINOX/FOLFOX response in advanced pancreatic cancer

Geriatric Assessment in older patients with pancreatic adenocarcinoma

1204MO PRODIGE 59 - DURIGAST trial: A randomised phase II study evaluating FOLFIRI plus durvalumab and FOLFIRI plus durvalumab plus tremelimumab in second-line treatment of patients with advanced gastric or gastro-oesophageal junction adenocarcinoma

LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial

Use of bevacizumab in elderly patients with metastatic colorectal cancer: Review

1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)

1555P Cell-free DNA analysis in patients with metastatic gastroesophageal adenocarcinoma: Preliminary results of the REGIRI - PRODIGE 58 ancillary study

LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study

PO-1084: Stereotactic pelvic reirradiation for locoregional cancer relapse

IgG4-related systemic disease: Report of a case in an elderly patient

Transnational Trade Unionism: Building Union Power

LBA60 Evaluation of gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma: Results of the randomized phase III PRODIGE 65 - UCGI 36 - GEMPAX UNICANCER study

1566TiP PRODIGE 65 - UCGI 36 - GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

Suchergebnisse filtern